3
Announcements
Trials
Browse
Landscape
Status
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Conditions
Dermatitis, Atopic
1
Interventions
Surveys and Questionnaires
38
Blood Specimen Collection
24
Specimen Handling
14
Radiotherapy
12
Surgical Procedures, Operative
10
Interviews as Topic
10
Observation
9
Magnetic Resonance Spectroscopy
9
Drug Therapy
9
Data Collection
8
Immunotherapy
7
Watchful Waiting
5
Tomography, X-Ray Computed
5
Radiosurgery
5
Nivolumab
5
Mastectomy, Segmental
5
Biopsy
5
ribociclib
4
palbociclib
4
Therapeutics
4
Positron Emission Tomography Computed Tomography
4
Mental Status and Dementia Tests
4
Magnetic Resonance Imaging
4
Ipilimumab
4
Immune Checkpoint Inhibitors
4
High-Throughput Nucleotide Sequencing
4
Echocardiography
4
Bevacizumab
4
lorlatinib
3
atezolizumab
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
Observational
×
pimecrolimus
×
Clear all
NCT00568997
2025-09-16
PEER
Bausch Health Americas, Inc.
Active not recruiting
8,000 enrolled